Regulation of Cardiac Remodeling by Nitric Oxide: Focus on Cardiac Myocyte Hypertrophy and Apoptosis

作者: Kai C. Wollert , Helmut Drexler

DOI: 10.1023/A:1020706316429

关键词: MediatorHeart diseaseCardiac myocyteMyocyteMedicineNitric oxide synthaseNitric oxideEndocrinologyMuscle hypertrophyHeart failureInternal medicine

摘要: Cardiac hypertrophy occurs in pathological conditions associated with chronic increases hemodynamic load. Although can initially be viewed as a salutary response, ultimately, it often enters phase of remodeling that may lead to heart failure and premature death. A prevailing concept predicts changes gene expression hypertrophied cardiac myocytes myocyte loss by apoptosis contribute the transition from failure. In recent years, nitric oxide (NO) has emerged an important regulator remodeling. Specifically, NO been recognized potent antihypertrophic proapoptotic mediator cultured myocytes. Studies genetically engineered mice have extended these findings vivo situation. It appears low levels transient release endothelial synthase exert beneficial effects on process reducing hypertrophy, cavity dilation mortality. By contrast, high sustained production inducible seem maladaptive ventricular contractile function, increasing apoptosis, future, novel insights into role should allow development therapeutic strategies treat

参考文章(65)
Rebecca H. Ritchie, Rick J. Schiebinger, Margot C. Lapointe, James D. Marsh, Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide American Journal of Physiology-heart and Circulatory Physiology. ,vol. 275, ,(1998) , 10.1152/AJPHEART.1998.275.4.H1370
Norbert Frey, Timothy A. McKinsey, Eric N. Olson, Decoding calcium signals involved in cardiac growth and function Nature Medicine. ,vol. 6, pp. 1221- 1227 ,(2000) , 10.1038/81321
Hiroki Aoki, Junichi Sadoshima, Seigo Izumo, Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro Nature Medicine. ,vol. 6, pp. 183- 188 ,(2000) , 10.1038/72287
A. Thorburn, J. Thorburn, S.Y. Chen, S. Powers, H.E. Shubeita, J.R. Feramisco, K.R. Chien, HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. Journal of Biological Chemistry. ,vol. 268, pp. 2244- 2249 ,(1993) , 10.1016/S0021-9258(18)53988-0
G. Christensen, Y. Wang, K. R. Chien, Physiological assessment of complex cardiac phenotypes in genetically engineered mice American Journal of Physiology-heart and Circulatory Physiology. ,vol. 272, ,(1997) , 10.1152/AJPHEART.1997.272.6.H2513
Modem Suhasini, Hien Li, Suzanne M. Lohmann, Gerry R. Boss, Renate B. Pilz, Cyclic-GMP-Dependent Protein Kinase Inhibits the Ras/Mitogen-Activated Protein Kinase Pathway Molecular and Cellular Biology. ,vol. 18, pp. 6983- 6994 ,(1998) , 10.1128/MCB.18.12.6983
Rohit Khurana, John F. Martin, Ian Zachary, Gene Therapy for Cardiovascular Disease A Case for Cautious Optimism Hypertension. ,vol. 38, pp. 1210- 1216 ,(2001) , 10.1161/HY1101.099483
Flora Sam, Douglas B. Sawyer, Zhonglin Xie, Donny L.F. Chang, Soeun Ngoy, Daniel A. Brenner, Deborah A. Siwik, Krishna Singh, Carl S. Apstein, Wilson S. Colucci, Mice Lacking Inducible Nitric Oxide Synthase Have Improved Left Ventricular Contractile Function and Reduced Apoptotic Cell Death Late After Myocardial Infarction Circulation Research. ,vol. 89, pp. 351- 356 ,(2001) , 10.1161/HH1601.094993
Jean-Luc Balligand, Paul J. Cannon, Nitric Oxide Synthases and Cardiac Muscle Autocrine and Paracrine Influences Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 17, pp. 1846- 1858 ,(1997) , 10.1161/01.ATV.17.10.1846